A randomized phase 2, single-blind study of temozolomide (TMZ) and radiotherapy (RT) combined with nivolumab or placebo (PBO) in newly diagnosed adult patients (pts) with tumor O6-methylguanine DNA methyltransferase (MGMT)-methylated glioblastoma (GBM)—Ch
Year: 2016
Type: article
Authors: Weller, M, Vlahovic, G, Khasraw, Mustafa, Brandes, AA, Zwirtes, R, Tatsuoka, K, Carpentier, AF, Reardon, DA, Bent, M
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W6986722905
